The PSA Test



Prostate Cancer Canada Recommends:

1. Men should get a PSA test in their 40s to establish their baseline.

2. Men at high risk for prostate cancer should talk to their primary care provider before age 40 about prostate cancer.

3. At or over age 70, the decision to end prostate cancer screening should be based on an informed discussion with their primary care provider.

 



What is Prostate Specific Antigen (PSA)?

Prostate Specific Antigen (PSA) is a protein produced within the prostate gland and is secreted into seminal fluid.

There are two types of PSA:
  1. Free PSA: moves freely in the blood as it is unbound to other proteins  
  2. Complex PSA: attached to other proteins as it moves around the blood

Free PSA comes from benign prostatic hyperplasia (BPH), an enlargement of the prostate. The higher the amount of free PSA, the less likely prostate cancer will be found as prostate cancer cells produce more complex PSA.

What is the PSA test?

The PSA test is a simple blood test, taken from the arm, which measures the amount of PSA protein in the blood. It is common for PSA to be found in the blood in very small concentrations. Higher levels of PSA may indicate the presence of cancer, but can also be an indicator of other prostate conditions.  

What are the benefits and limitations of the PSA test?


Benefits Limitations
May indicate the presence of cancer in its earliest stages. May lead to unnecessary tests and treatment.
Simple blood test (not harmful). Cannot distinguish between slow growing and advanced cancer.
Currently only test we have as red flag to indicate follow-up. The PSA test cannot diagnose prostate cancer but can tell you if there’s a problem with the prostate.


While the PSA test is not currently used in Canada as a population-wide screening tool, it is used to monitor how someone responds to cancer treatment or to monitor disease recurrence or progression.





RELEVANT LINKS
PCC's Position Paper on PSA Testing
PCC's PSA Recommendation: News Release
Infographic: Know Your Number
Infogrpahic: What Affects PSA Values
Support PSA Tests


Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
Prostate Cancer Canada reminds men that early detection using ‘Smart Screening’ for prostate cancer

Toronto, ON – October 27, 2014 – Prostate Cancer Canada responds today to guidelines released from The Canadian Task Force on Preventive Health Care (CTFPHC) recommending that the Prostate Specific Antigen (PSA) test should be eliminated as a screening tool for prostate cancer. More

Prostate Cancer Canada fundraiser to donate 50% of proceeds to families of fallen soldiers

TORONTO, ON, October 24, 2014 – Following the death of two Canadian soldiers, Prostate Cancer Canada will donate half of the net proceeds raised by the Pants Off for Prostate Cancer Ottawa fundraising event, presented by Alterna Savings, to the Stand On Guard fund. More


Click here for news archive